早孕期第三届胎儿医学基金会竞争风险模型对小于胎龄儿的验证
这项回顾性多中心队列研究纳入3012例单胎妊娠孕妇,在孕30+0至34+0周进行超声检查,验证胎儿医学基金会36周竞争风险模型预测小于胎龄儿的准确性。模型结合母体因素、估计胎儿体重和子宫动脉搏动指数,在10%假阳性率下对小于第3百分位小于胎龄儿的检出率分别为88.0%(<37周分娩)、74.4%(<40周)和72.8%(<42周)。结论认为该模型在孕30+0至34+0周同样适用且校准良好,尤其对<37周分娩病例风险分层有效。
要点
- 孕30+0至34+0周应用该模型预测小于胎龄儿,加入子宫动脉搏动指数可改善检出。
- 10%假阳性率下,对<37周分娩的小于第3百分位小于胎龄儿检出率为88.0%。
- 若欲检出90%的小于第10百分位小于胎龄儿,初次评估后2周内需筛查10.8%人群。
核心结论
- 36周胎儿医学基金会竞争风险模型在孕30+0至34+0周同样适用且准确,可有效进行风险分层,尤其对<37周分娩病例。
研究设计与样本
- 回顾性多中心队列研究,前瞻性收集3012例单胎妊娠孕妇数据,在孕30+0至34+0周作为普遍筛查项目的一部分进行超声检查。
主要发现
- 在10%假阳性率下,母体因素、估计胎儿体重和子宫动脉搏动指数预测<37、<40和<42周分娩的小于第3百分位小于胎龄儿的比例分别为88.0%、74.4%和72.8%。
- 对小于第10百分位小于胎龄儿,上述三个分娩时间点的检出率分别为86.1%、69.3%和66.2%。
- 若以估计胎儿体重和子宫动脉搏动指数为生物标志物、目标检出90%的小于第10百分位小于胎龄儿,初次评估后2周内应筛查10.8%人群,2-4周内额外筛查7.2%(总筛查阳性率18.0%),4-6周内额外筛查11.7%(总筛查阳性率29.7%)。
- 新模型校准良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the new 36-week Fetal Medicine Foundation (FMF) competing-risks model for the prediction of small-for-gestational age (SGA) at an earlier gestation of 30 + 0 to 34 + 0 weeks. METHODS: This was a retrospective multicenter cohort study of prospectively collected data on 3012 women with a singleton pregnancy undergoing ultrasound examination at 30 + 0 to 34 + 0 weeks' gestation as part of a universal screening program. We used the default FMF competing-risks model for prediction of SGA at 36 weeks' gestation combining maternal factors (age, obstetric and medical history, weight, height, smoking status, race, mode of conception), estimated fetal weight (EFW) and uterine artery pulsatility index (UtA-PI) to calculate risks for different cut-offs of birth-weight percentile and gestational age at delivery. We examined the accuracy of the model by means of discrimination and calibration. RESULTS: The prediction of SGA < 3rd percentile improved with the addition of UtA-PI and with a shorter examination-to-delivery interval. For a 10% false-positive rate, maternal factors, EFW and UtA-PI predicted 88.0%, 74.4% and 72.8% of SGA < 3rd percentile delivered at < 37, < 40 and < 42 weeks' gestation, respectively. The respective values for SGA < 10th percentile were 86.1%, 69.3% and 66.2%. In terms of population stratification, if the biomarkers used are EFW and UtA-PI and the aim is to detect 90% of SGA < 10th percentile, then 10.8% of the population should be scanned within 2 weeks after the initial assessment, an additional 7.2% (total screen-positive rate (SPR), 18.0%) should be scanned within 2-4 weeks after the initial assessment and an additional 11.7% (total SPR, 29.7%) should be examined within 4-6 weeks after the initial assessment. The new model was well calibrated. CONCLUSIONS: The 36-week FMF competing-risks model for SGA is also applicable and accurate at 30 + 0 to 34 + 0 weeks and provides effective risk stratification, especially for cases leading to delivery < 37 weeks of gestation. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Dagklis T, Papastefanou I, Tsakiridis I, et al. Validation of Fetal Medicine Foundation competing-risks model for small-for-gestational-age neonate in early third trimester. Ultrasound Obstet Gynecol. 2024. PMID: 37743681. doi:10.1002/uog.27498
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。